Stock Comparison
GMAB vs VRTX
Genmab AS and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$19.78B
$123.94B
P/E (TTM)
25.0
28.5
Forward P/E
18.4
25.7
Price/Sales
4.8
9.9
Price/Book
3.3
6.1
EV/EBITDA
18.3
23.2
Dividend Yield
—
—
Profitability
Net Margin
21.05%
35.40%
Operating Margin
32.99%
38.97%
Return on Equity
14.00%
23.50%
Return on Assets
8.79%
11.90%
Growth (YoY)
Revenue Growth
24.90%
12.50%
Earnings Growth
-9.40%
8.00%
Price & Risk
Beta
0.7
0.3
52-Week High
$35.34
$529.65
52-Week Low
$22.98
$376.62
Analyst Target
$38.46
$559.28
Compare GMAB and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.